Patrick Truesdell - Feb 28, 2023 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
Vice President and Controller
Signature
/s/ Patrick Truesdell
Stock symbol
LABP
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:09 PM
Previous filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Employee Stock Option (right to buy) Award $0 +99.6K $0.00 99.6K Feb 28, 2023 Common Stock 99.6K $0.37 Direct F1
transaction LABP Restricted Stock Unit Award $0 +99.6K $0.00 99.6K Feb 28, 2023 Common Stock 99.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
F2 Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
F3 The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.